Organovo Holdings, Inc.
ONVO
Classement en actions
#36082
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Prix de l'action
$2.00
Dernière synchronisation: 2025-05-19
Capitalisation boursière
$2.93M
Changement (1 jour)
-3.38%
Changement (1 an)
656.14%
Pays
US
Échange Organovo Holdings, Inc. (ONVO)
Catégorie
Healthcare
Capitalisation boursière de Organovo Holdings, Inc.(ONVO)
Capitalisation boursière: $2.93M
En October 2026, Organovo Holdings, Inc. a une capitalisation boursière de $2.93M. Cela fait de Organovo Holdings, Inc. la 36082nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Organovo Holdings, Inc. du 2014 au 2026
ONVO par rapport au top 5 des plus populaires stocks
